Analytical Technician – Early Phase Biopharmaceutical Products
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Ballerup
A chance to be part of an ambiguous and flexible laboratory group in LEO CMC area
LEO Pharma has embarked on a growth journey to become the preferred dermatology care partner in the world, dedicated to help people achieve healthy skin. We have an ambitious 2030 strategy, which aims to accelerate our impact in protein- based therapeutics while strengthening our established portfolio and our global footprint in medical dermatology. Dermatology is an area of rapid growth and LEO Pharma´s vision is to help people with mild, moderate and severe dermatological diseases across the world. To meet the requirements of an increasing pipeline of biologics projects we are now expanding in the CMC biologics area both in terms of capabilities and capacity. This is why we need you!
Biopharmaceutical Product early phase analysis
Your overall focus will be screening, characterization and analysis of monoclonal antibodies (mAbs)in close collaboration with formulation and analytical scientists to support our early phase lab activities. You will be responsible for sample preparation, developing analytical methods, maintaining analytical equipment, write analytical procedures, , data analysis of your own experiments and documenting the data and results in ELN . You will be working with the team to deliver high quality results for the projects in early phase development, and you will also work with colleagues from the bioprocess department.
Your primary tasks will be:
As we are breaking new ground and are part of an R&D organisation, no two days are alike. As such, you must be able to thrive in a dynamic R&D environment and have the drive and entrepreneurial spirit to move things ahead.
+3 years’ experience within biopharmaceutical product analysis
You have an education as Laboratory Technician or similar with at least 3 years’ experience in protein analysis and characterization. Your career has provided you with hands-on experience within development of analytical methods for mAbs or other proteins as well as with experience with solving day-to-day tasks within the laboratory. You have worked with and have an interest for new technologies in the analytical area and have a flair for equipment and problem solving.
You are curious by nature and like to try new things, methods, processes etc. You combine strong bench skills with a good sense for documentation to ensure the right quality in your deliverables. As you will work together with multiple people across the LEO organisation, good collaboration skills are of great importance.
Biopharmaceutical Products – your new department
Your will join a team of eight (today) skilled colleagues covering early phase biopharmaceutical competencies. We are a growing team, and our focus is to support selection of stable mAbs and development of stabilizing formulations for LEO Pharma’s portfolio of biologics. We aim to establish an innovation culture characterised by openness, plenty of room for new ideas, mutual respect and helpfulness – while not forgetting to have a good time together. The department is part of Biologics & Early Development consisting of 55+ highly skilled and dedicated colleagues striving to deliver high quality science to progress our Research and Development projects and to deliver innovative products to patients.
We are here to take ownership, drive, and secure that scientific questions are both raised and answered within Biologics. We are driven by a high level of integrity, science, passion for our work and an open minded, collaborative approach.
The position is placed in the LEO Pharma headquarters in Ballerup.
We will be reviewing applications on an ongoing basis, and look forward to receiving your application in English or Danish no later than 15th of April 2021. If you would like to learn more please contact Christer Andersson, Senior Manager of Biopharmaceutical Products (+45 31 38 59 86) or Lars Dencker Principal Analytical Scientist (+45 22 45 35 82) or Heidi Westh Bagger Principal Analytical Scientist ( +45 31 35 20 53)
About LEO Pharma
LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 100 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. LEO Pharma is headquartered in Denmark and employs around 6,000 people worldwide. For more information, visit www.leo-pharma.com
LEO Pharma has embarked on a growth journey to become the preferred dermatology care partner in the world, dedicated to help people achieve healthy skin. We have an ambitious 2030 strategy, which aims to accelerate our impact in protein- based therapeutics while strengthening our established portfolio and our global footprint in medical dermatology. Dermatology is an area of rapid growth and LEO Pharma´s vision is to help people with mild, moderate and severe dermatological diseases across the world. To meet the requirements of an increasing pipeline of biologics projects we are now expanding in the CMC biologics area both in terms of capabilities and capacity. This is why we need you!
Biopharmaceutical Product early phase analysis
Your overall focus will be screening, characterization and analysis of monoclonal antibodies (mAbs)in close collaboration with formulation and analytical scientists to support our early phase lab activities. You will be responsible for sample preparation, developing analytical methods, maintaining analytical equipment, write analytical procedures, , data analysis of your own experiments and documenting the data and results in ELN . You will be working with the team to deliver high quality results for the projects in early phase development, and you will also work with colleagues from the bioprocess department.
Your primary tasks will be:
- Protein analyses by CIEX, CIEF, SEC, SEC-MALS, CE-SDS and DLS . Additional analyses including SVP analyses might be part of our analytical toolbox the coming years
- Method development and forced degradation studies
- Handling of large number of protein samples for screening studies and developability assessment of mAb candidate
- Setting up and conducting protein stability studies including several analytical methods
- Maintain a balance between experimental work and solid documentation of work and data
- Take part in troubleshooting using the joined analytical knowledge of the early phase group.
As we are breaking new ground and are part of an R&D organisation, no two days are alike. As such, you must be able to thrive in a dynamic R&D environment and have the drive and entrepreneurial spirit to move things ahead.
+3 years’ experience within biopharmaceutical product analysis
You have an education as Laboratory Technician or similar with at least 3 years’ experience in protein analysis and characterization. Your career has provided you with hands-on experience within development of analytical methods for mAbs or other proteins as well as with experience with solving day-to-day tasks within the laboratory. You have worked with and have an interest for new technologies in the analytical area and have a flair for equipment and problem solving.
You are curious by nature and like to try new things, methods, processes etc. You combine strong bench skills with a good sense for documentation to ensure the right quality in your deliverables. As you will work together with multiple people across the LEO organisation, good collaboration skills are of great importance.
Biopharmaceutical Products – your new department
Your will join a team of eight (today) skilled colleagues covering early phase biopharmaceutical competencies. We are a growing team, and our focus is to support selection of stable mAbs and development of stabilizing formulations for LEO Pharma’s portfolio of biologics. We aim to establish an innovation culture characterised by openness, plenty of room for new ideas, mutual respect and helpfulness – while not forgetting to have a good time together. The department is part of Biologics & Early Development consisting of 55+ highly skilled and dedicated colleagues striving to deliver high quality science to progress our Research and Development projects and to deliver innovative products to patients.
We are here to take ownership, drive, and secure that scientific questions are both raised and answered within Biologics. We are driven by a high level of integrity, science, passion for our work and an open minded, collaborative approach.
The position is placed in the LEO Pharma headquarters in Ballerup.
We will be reviewing applications on an ongoing basis, and look forward to receiving your application in English or Danish no later than 15th of April 2021. If you would like to learn more please contact Christer Andersson, Senior Manager of Biopharmaceutical Products (+45 31 38 59 86) or Lars Dencker Principal Analytical Scientist (+45 22 45 35 82) or Heidi Westh Bagger Principal Analytical Scientist ( +45 31 35 20 53)
About LEO Pharma
LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 100 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. LEO Pharma is headquartered in Denmark and employs around 6,000 people worldwide. For more information, visit www.leo-pharma.com
Information og data
Denne ledige stilling har jobtypen "Kemiker", og befinder sig i kategorien "Sundhed og forskning".
Arbejdsstedet er beliggende i Ballerup.
Jobbet er oprettet på vores service den 12.3.2021, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Kemiker
- Ballerup
- Torsdag den 15. april 2021
Lignende jobs
-
Projektkemiker med interesse for peptid, protein, ...
Lægemiddel og Misbrugsanalytisk Enhed (LME) og Forskning sektionen på Klinisk Biokemisk Afdeling, Bispebjerg og Frederiksberg Hospital søger pr. 1. januar 2025 (eller efter aftale) en projektkemike..Få mere info- Kemiker
- Storkøbenhavn
-
Projektkemiker med interesse for peptid, protein, ...
Lægemiddel og Misbrugsanalytisk Enhed (LME) og Forskning sektionen på Klinisk Biokemisk Afdeling, Bispebjerg og [xxxxx] søger pr. 1. januar 2025 (eller efter aftale) en projektkemi..Få mere info- Kemiker
- København NV
-
Projektkemiker med interesse for peptid, protein, ...
Lægemiddel og Misbrugsanalytisk Enhed (LME) og Forskning sektionen på Klinisk Biokemisk Afdeling, Bispebjerg og Frederiksberg Hospital søger pr. 1. januar 2025 (eller efter aftale) en projektkemike..Få mere info- Kemiker
- København NV
-
Kemiker/radiokemiker til Afdeling for Klinisk Fysi...
il Cyklotron og Radiokemi på Afdeling for Klinisk Fysiologi og Nuklear Medicin på [xxxxx] søges en engageret og dynamisk radiokemiker til arbejde med produktion, kvalitetskontrol (QC) og k..Få mere info- Kemiker
- København N
Statistik over udbudte jobs som kemikere i Ballerup
Herunder ser du udviklingen i udbudte kemiker i Ballerup over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal kemikere.
Se flere statistikker her:
Statistik over udbudte kemikere i Ballerup over tid
| Dato | Alle jobs som kemikere |
|---|---|
| 27. november 2024 | 0 |
| 26. november 2024 | 0 |
| 25. november 2024 | 0 |
| 24. november 2024 | 0 |
| 23. november 2024 | 0 |
| 22. november 2024 | 0 |
| 21. november 2024 | 0 |
| 20. november 2024 | 0 |
| 19. november 2024 | 0 |
| 18. november 2024 | 0 |
| 17. november 2024 | 0 |
| 16. november 2024 | 0 |
| 15. november 2024 | 0 |
| 14. november 2024 | 0 |
| 13. november 2024 | 0 |
| 12. november 2024 | 0 |
| 11. november 2024 | 0 |
| 10. november 2024 | 0 |
| 9. november 2024 | 0 |
| 8. november 2024 | 0 |
| 7. november 2024 | 0 |
| 6. november 2024 | 0 |
| 5. november 2024 | 0 |
| 4. november 2024 | 0 |
| 3. november 2024 | 0 |
| 2. november 2024 | 0 |
| 1. november 2024 | 0 |
| 31. oktober 2024 | 0 |
| 30. oktober 2024 | 0 |
| 29. oktober 2024 | 0 |
| 28. oktober 2024 | 0 |